AI-quantum framework for accurate infertility risk classification in PCOS patients using EHR data.

INTRODUCTION

Infertility affects nearly one in six couples worldwide, with approximately half of these cases associated with female-related factors. Among women, ovulatory disorders represent a major cause of infertility, with Polycystic Ovary Syndrome (PCOS) being one of the most prevalent conditions. Traditional diagnostic methods, including ultrasound imaging, hormone analysis, and menstrual history evaluation, often fail to fully utilize comprehensive patient health records. These records contain important clinical indicators such as body mass index (BMI), Anti-Müllerian Hormone (AMH) levels, follicle count, and menstrual irregularities, which may provide deeper insights into infertility risk.

METHODS

This study proposes a novel AI-quantum hybrid framework for analyzing PCOS-related health records to improve infertility risk prediction. The framework integrates classical deep learning techniques with quantum-inspired models, including Long Short-Term Memory (LSTM) and Quantum LSTM architectures, to capture long-term dependencies in sequential clinical data. The proposed models are trained and evaluated using a PCOS dataset containing multiple clinical attributes relevant to reproductive health.

RESULTS

The experimental analysis demonstrates that the hybrid AI-quantum framework effectively identifies complex relationships within clinical data and improves infertility risk classification compared with traditional machine learning approaches. The model shows enhanced capability in handling heterogeneous and incomplete health records while maintaining robust predictive performance.

DISCUSSION AND

CONCLUSION

The findings highlight the potential of integrating artificial intelligence with quantum-inspired computing techniques to support early detection of infertility risks associated with PCOS. The proposed framework can assist clinicians in identifying high-risk patients more efficiently and may contribute to personalized reproductive healthcare and improved diagnostic accuracy.